Viridos

Company

Investment-firm

Last deal

$25M

Amount

Series A

Stage

13.03.2023

Date

3

all rounds

$202M

Total amount

Financing round

General

About Company
Synthetic Genomics develops genomic-driven solutions for global energy and environmental challenges.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Synthetic Genomics

founded date

01.01.2005

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The company uses DNA synthesis and programming to design and develop microbes for industrial processes and environmental applications. They also create advanced biofuels, harness photosynthetic organisms to produce products from sunlight and carbon dioxide, and develop new biological solutions to enhance production and recovery rates of subsurface hydrocarbons. Their solutions help improve energy, chemical, and pharmaceutical production, enable carbon sequestration, and aid in environmental remediation. Viridos, a privately held biotechnology company, uses algal genetics to produce low-carbon intensity biofuels for aviation, commercial trucking, and maritime shipping, with a goal of creating a sustainable bioeconomy.
Contacts
Similar Companies
1000
Molecular Assemblies

Molecular Assemblies

Molecular Assemblies is a San Diego-based company developing revolutionary enzymatic DNA synthesis technology for powering new products.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology

Location

San Diego, CA, USA

total rounds

10

total raised

$91.17M
Twist Bioscience

Twist Bioscience

Twist Bioscience is a synthetic biology company that develops a silicon-based manufacturing process for the production of synthetic DNA.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Chemical, Manufacturing

Location

San Francisco, CA, USA

total rounds

10

total raised

$553.11M

count Of Investments

1
Radiant Genomics

Radiant Genomics

Radiant Genomics developed an industrial platform for natural product and gene discovery.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology

Location

Emeryville, CA, USA
MetaMixis

MetaMixis

MetaMixis is revolutionizing enzyme and pathway discovery to drive the emergence of the bioeconomy.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Chemical

Location

Vancouver, BC, Canada

total rounds

4

total raised

$100K

Financials

Funding Rounds
11
3

Number of Funding Rounds

$202M

Money Raised

Their latest funding was raised on 13.03.2023. Their latest investor US Department of Energy. Their latest round Series A

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Breakthrough Energy Ventures

Breakthrough Energy Ventures

Breakthrough Energy Ventures invests in new technologies that provide reliable and affordable power without contributing to climate change.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Clean Energy, Energy, Information Technology

Location

Paris, France

count Of Investments

166

count Of Exists

2
US Department of Energy

US Department of Energy

The US Department of Energy addresses energy, environmental, and nuclear challenges through transformative science and technology.

Sector

Oil, Gas and Coal

Subsector

Oil Equipment and Services

Location

Washington Cir NW, Washington, DC, USA

count Of Investments

1136

count Of Exists

29

Governor Newsom’s Office of Business & Economic Development

GO-Biz is a government entity promoting economic growth and supporting businesses in California.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Government, Business Development, Non-Profit

count Of Investments

4
Investments
1
Date 
name 
Lead 
type 
Raised 
04.03.2014
No
$80M
Human Longevity

Human Longevity

Human Longevity is a genomic-based health intelligence company that empowers proactive healthcare and enables a better life.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Medical

Location

San Diego, CA, USA

total rounds

6

total raised

$380.3M

count Of Investments

4
Co-Investors
Investors
13
6

Number of lead investors

13

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series A
US Department of Energy

US Department of Energy

The US Department of Energy addresses energy, environmental, and nuclear challenges through transformative science and technology.

Sector

Oil, Gas and Coal

Subsector

Oil Equipment and Services

Location

Washington Cir NW, Washington, DC, USA

count Of Investments

1136

count Of Exists

29

United Airlines Ventures

United Airlines Ventures is a corporate venture firm in the aviation industry.

Sector

Industrial Transportation

Subsector

Commercial Vehicle and Equipment Leasing

count Of Investments

10
Chevron

Chevron

Chevron Corporation is a global energy and technology company.

Sector

Oil, Gas and Coal

Subsector

Oil Equipment and Services

Keywords

Energy, Oil and Gas, Manufacturing

Location

San Ramon, CA, USA

count Of Investments

13

count Of Exists

4

People

Founders
4
J. Venter
J. Venter

J. Venter

Craig Venter is the Founder, President and Chairman of J. Craig Venter Institute.

current job

J. Craig Venter Institute
J. Craig Venter Institute

organization founded

6

J. Venter

Juan Enriquez
Juan Enriquez

Juan Enriquez

Juan Enriquez is a Managing Director at Excel Venture Management. He is a leading authority on the economic impact of life sciences on business and society, and a respected business leader and entrepreneur. He represents Excel on the boards of Shape Up the Nation, Fina Technologies, Catch.com, and Synthetic Genomics, as well as Activate Networks. Prior to Excel, Enriquez was the Founding Director of the Harvard Business School’s Life Sciences Project, with many of his innovative thoughts captured in his bestselling book, As the Future Catches You, which provides an accurate blueprint of how a bio-based economy changes industries and corporations. Following HBS, Enriquez became an active angel investor and founder of Biotechonomy Ventures, which invested in BioTrove, Xcellerex, and Synthetic Genomics, a company he co-founded with Drs. J. Craig Venter and Hamilton Smith, to apply life sciences to energy markets. As a business leader, advisor, and renowned speaker, he works directly with the CEOs of a number of Fortune Fifty companies, as well as with various heads of state, on how to adapt to a world where the dominant language is shifting from digital towards the language of life. He is a member of the Board of Directors of Cabot Corporation (NYSE: CBT), and he graduated from Harvard with a B.A. and M.B.A., both with honors.

current job

Excel Venture Management
Excel Venture Management

Juan Enriquez

David C. Kiernan
David C. Kiernan

David C. Kiernan

Dr. David C. Kiernan is a Co-Founder, Executive Vice President, and General Counsel at Synthetic Genomics Inc. He has an extensive scientific and medical background. Dr. Kiernan is also a senior litigation Partner at Williams & Connolly in Washington, DC, where his practice area of expertise encompasses commercial, intellectual property (patents and trade secrets), products liability, and personal injury. Dr. Kiernan's clients include major pharmaceutical and biotechnology companies. He is a leading healthcare attorney in the United States. Dr. Kiernan is a Member of Business Advisory Board at Excel Medical Ventures. He is a graduate of Duke University School of Medicine and Duke University Law School and holds J.D. and M.D. degrees.

current job

Viridos
Viridos

David C. Kiernan

Hamilton Smith
Hamilton Smith

Hamilton Smith

Dr. Hamilton O. Smith co-founded Synthetic Genomics, Inc. in 2005 and serves as it's Co-Chief Scientific Officer. Dr. Smith serves as a Scientific Director of the Institute of Biological Energy Alternatives(IBEA) and Scientific Director of Synthetic Biology & Biological Energy Groups at the Venter Institute. He served as an Executive Vice President at Synthetic Genomics, Inc. He served as a Founder and Senior Director of DNA Resources of Celera Genomics and participated in the sequencing of the genomes of the fruit fly, mosquito, mouse and human. Previously, Dr. Smith served as the head of faculty and professor of molecular biology and genetics of the Johns Hopkins University School of Medicine. He was a Co-Founder and collaborated with The Institute for Genome Research (TIGR) to sequence the genome of H. influenza, archaea bacteria, and other bacteria. Dr. Smith is widely considered one of the experts in DNA library construction and DNA manipulation techniques. He serves as the Chairman and Member of Scientific Advisory Board of Metabolon Inc. Dr. Smith serves as a Member of Scientific Advisory Board at U.S. Genomics, Inc. and Excel Medical Ventures. He serves as a Director of Sunol Molecular Corporation. Dr. Smith was a Member of Scientific Advisory Board at Intercell Biomedical Research & Development AG until February 2006.

current job

Celera
Celera

organization founded

2

Hamilton Smith

Employee Profiles
77

Shaun Bailey

Senior director

Louis Brown

Head of phototrophic production r and d

Shigeki Miyake-Stoner

Scientist ii - algae engineering

Brittney Maxey

Human resources manager

Joshua Gurr

Scientist

Iara Rocchi

Research associate ii, molecular biology - temp

Danielle Cheek

Research associate

Susan Fields

Senior buyer

Activity

Recent News
0